Almac Group
EMEA
Craigavon
,
United Kingdom
Multinational
FOUNDED
1968
HEADCOUNT
5001-10000
FUNDING
Privately held
Keywords:
CDMO, therapeutics, diagnostics, omics, biocatalysis, enzymes, directed_evolution
BUSINESS
Pharmaceutical services company providing API manufacture, formulation development, clinical trial supply, commercial-scale manufacturing, and diagnostic solutions. Serves biopharma clients across the drug development lifecycle.
BIOTECH INVOLVEMENT
Partial; pharma-services CDMO group whose industrial-biotech relevance sits in Almac Sciences' biocatalysis unit (Belfast): gene identification, expression, fermentation of biocatalysts, directed evolution and computational enzyme engineering (INSIGHT, selectAZyme platforms), enzyme immobilization, and multi-tonne biotransformation for chiral APIs. Other divisions (clinical, diagnostics, drug discovery) sit outside industrial biotech.
TECHNOLOGY PLATFORM
genomic services; clinical biomarker & CDx development
PRIMARY PRODUCTS
API manufacture; formulation development; clinical trial supply services; commercial manufacture; biomarker-driven clinical trials